DeepCyte

Wilmington, United States

DeepCyte is a biotechnology company that offers predictive products for toxicology using single-cell metabolomics technology.

Apr 2026

Seed

Top Investors

Carl Evertsz

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are DeepCyte's investors?

DeepCyte's investors include Carl Evertsz.

Where is DeepCyte headquartered?

DeepCyte is headquartered in Wilmington, United States.

What does DeepCyte do?

DeepCyte is a biotechnology company that offers predictive products for toxicology using single-cell metabolomics technology.

What stage is DeepCyte at?

DeepCyte is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 9, 2026.

MLA

"DeepCyte — Funding & Investors." VCBacked, April 9, 2026, https://www.vcbacked.co/company/deepcyte. Accessed June 13, 2026.

APA

VCBacked. (2026). DeepCyte — Funding & Investors. Retrieved June 13, 2026, from https://www.vcbacked.co/company/deepcyte

Wikipedia (cite web)

{{cite web |title=DeepCyte — Funding & Investors |url=https://www.vcbacked.co/company/deepcyte |website=VCBacked |access-date=June 13, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 9, 2026.